4 Shares Yielding More Than 5%: GlaxoSmithKline plc, SSE plc, Infinis Energy plc & John Laing Environmental Assets Group Lt

GlaxoSmithKline plc (LON:GSK), SSE plc (LON:SSE), Infinis Energy plc (LON:INFI) and John Laing Environmental Assets Group Lt (LON:JLEN) have dividend yields above 5%

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

GSK

GlaxoSmithKline (LSE: GSK) is struggling with the increase in generic competition, as its major blockbuster drugs lose patent protection. Advair, GSK’s best selling respiratory drug, saw revenues fall 21% to £392 million in the first quarter of 2015, as it faced a fall in market share and pricing pressures.

Although its consumer healthcare and vaccines business is doing better, weakness from its pharmaceutical business continues to act as a drag on earnings. With adjusted EPS expected to fall another 16% this year, GSK can no longer afford to sustain further dividend increases. Management has said that it intends to keep its dividend at 80 pence annually until 2018.

They also expect adjusted EPS will grow in the mid-to-high single digits over in the five years from 2016 onwards. But, intensifying competition for Advair could offset the gains from the sales of new respiratory products. So, despite its 5.9% dividend yield, GSK is relatively unattractive.

SSE

Weaker wholesale electricity prices had weakened the margins of SSE’s (LSE: SSE) wholesale electricity generation business, and this trend is likely to continue as lower fuel prices will continue to exert downward pressure on wholesale electricity prices. But, it’s diversified generation mix should dampen the effect of lower wholesale prices, because its renewable capacity depends more significantly on government subsidies. In addition, it is set to benefit from the introduction of the capacity market in 2018/9.

SSE’s sizeable regulated networks business means that its earnings are generally more stable than other power generators. With a regulated asset value of £7.35 billion, its regulated networks business now accounts for just over half of the utility company’s operating profits. Its regulated asset base is also growing rapidly with the need for more investment to connect generation from renewable sources. This should enable SSE to deliver sustainable dividend growth. Its shares currently yield 5.6%

Infinis Energy

Renewable energy generator, Infinis Energy (LSE: INFI) has an impressive dividend yield of 9.3%. Lower wholesale electricity prices and less windy conditions last summer caused adjusted net income to fall 7.6% to 36.3 million.

As the business is highly cash generative, the company had sufficient free cash flow to fund its dividend payments and its capital investment needs in 2014. Its strong pipeline of new wind projects should mean that Infinis Energy’s dividend yield is sustainable in the medium term.

Infinis Energy has 43 MW of new wind plant capacity currently in construction, which will be mostly be unaffected by the withdrawal of the government’s Renewables Obligation subsidy for onshore wind farms. Even under the new contract for difference (CfD) regime, returns are still attractive; and Infinis Energy plans to continue to meet its 700 MW of renewable generation capacity target by 2017.

With a dividend yield of over 9%, Infinis Energy is an attractive income stock.

John Laing Environmental Assets

Structured in a similar way as John Laing Infrastructure Fund (LSE: JLIF), John Laing Environmental Assets (LSE: JLEN) invests primarily in in renewable energy, water treatment and waste management projects.

The fund targets an internal rate of return (IRR) of between 7.5% to 8.5%, and its fund manager currently charges a 1.0% management fee of the fund’s adjusted portfolio value. Even with the end of Renewables Obligation subsidy for onshore wind farms, the fund still has an attractive investment pipeline.

Its shares currently trade at a 4.3% premium to its net asset value (NAV), and yields 5.6%. The fund’s dividend is expected to grow in line with RPI inflation, but NAV growth is likely to be limited. This should mean that capital appreciation for the fund is also going to be limited.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »